Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Eric A. Wold
BH4 Domain of BCL-2 as a Novel Target for Cancer Therapy
Drug Discovery Today
Drug Discovery
Pharmacology
Discovery and Development of Natural Product Oridonin-Inspired Anticancer Agents
European Journal of Medicinal Chemistry
Medicine
Organic Chemistry
Drug Discovery
Pharmacology
Related publications
BH4 Domain Peptides Derived From BCL-2/BCL-Xl as Novel Tools Against Acute Pancreatitis
Cell Death Discovery
Cancer Research
Molecular Neuroscience
Immunology
Cell Biology
Cellular
NH2-terminal BH4 Domain of BCL-2 Is Functional for Heterodimerization With Bax and Inhibition of Apoptosis
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Targeting the BCL-2 Family for Cancer Therapy
Expert Opinion on Therapeutic Targets
Molecular Medicine
Drug Discovery
Clinical Biochemistry
Pharmacology
The Pluripotency Factor Musashi-2 Is a Novel Target for Lung Cancer Therapy
Annals of the American Thoracic Society
Pulmonary
Respiratory Medicine
Genome-Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1 as a Novel Target for Cancer Therapy
American Journal of Pathology
Forensic Medicine
Pathology
P68 RNA Helicase as a Molecular Target for Cancer Therapy
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
P68 RNA Helicase as a Molecular Target for Cancer Therapy
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Lipoprotein Lipase as a Candidate Target for Cancer Prevention/Therapy
Biochemistry Research International
Biochemistry
Chemoimmunotherapy as a Novel Cancer Therapy
Immunoregulation